Biodistribution of 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of amount injected and route of administration

This publication has 16 references indexed in Scilit:

• Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney
  European Journal of Nuclear Medicine and Molecular Imaging, 2001
• Intraoperative tumour detection using 111 In-DTPA- D -Phe 1 -octreotide and a scintillation detector
  European Journal of Nuclear Medicine and Molecular Imaging, 2001
• End-stage renal disease after treatment with 90 Y-DOTATOC
  European Journal of Nuclear Medicine and Molecular Imaging, 2001
• Biokinetics of 111In-DTPA-D-Phe1-octreotide in nude mice transplanted with a human carcinoid tumor
  Nuclear Medicine and Biology, 2001
• Preclinical Comparison in AR4-2J Tumor-Bearing Mice of Four Radiolabeled 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Somatostatin Analogs for Tumor Diagnosis and Internal Radiotherapy
  Endocrinology, 2000
• Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors
  Nuclear Medicine and Biology, 1999
• Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection
  British Journal of Surgery, 1994
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• Somatostatin receptors in meningiomas
  Nuclear Medicine Communications, 1993
• In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats
  Life Sciences, 1991